Concepts (81)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Antigens, CD19 | 1 | 2024 | 424 | 0.740 |
Why?
|
Cholangitis | 1 | 2020 | 111 | 0.660 |
Why?
|
Interleukin 1 Receptor Antagonist Protein | 1 | 2020 | 299 | 0.620 |
Why?
|
Tumor Burden | 1 | 2024 | 1892 | 0.610 |
Why?
|
Interleukin-13 | 1 | 2020 | 392 | 0.590 |
Why?
|
Olfaction Disorders | 1 | 2020 | 224 | 0.580 |
Why?
|
Pancreaticoduodenectomy | 1 | 2020 | 509 | 0.550 |
Why?
|
Interleukin-4 | 1 | 2020 | 1154 | 0.530 |
Why?
|
Lymphoma, B-Cell | 1 | 2022 | 938 | 0.510 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2024 | 1405 | 0.450 |
Why?
|
Immunotherapy, Adoptive | 1 | 2022 | 1468 | 0.410 |
Why?
|
Tumor Microenvironment | 1 | 2024 | 3869 | 0.370 |
Why?
|
Cytokines | 1 | 2020 | 7386 | 0.240 |
Why?
|
Adenocarcinoma | 1 | 2020 | 6340 | 0.210 |
Why?
|
Practice Guidelines as Topic | 1 | 2020 | 7400 | 0.210 |
Why?
|
Pancreatic Neoplasms | 1 | 2020 | 5366 | 0.200 |
Why?
|
Melanoma | 1 | 2020 | 5694 | 0.190 |
Why?
|
Germany | 1 | 2022 | 872 | 0.170 |
Why?
|
Smell | 1 | 2020 | 259 | 0.150 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2024 | 1372 | 0.140 |
Why?
|
Sarcoidosis, Pulmonary | 1 | 2013 | 45 | 0.110 |
Why?
|
Chemokine CXCL9 | 1 | 2013 | 135 | 0.110 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2024 | 1640 | 0.110 |
Why?
|
Immunoglobulin G | 1 | 2024 | 4538 | 0.100 |
Why?
|
Chemokine CXCL10 | 1 | 2013 | 309 | 0.100 |
Why?
|
Biopsy | 1 | 2024 | 6781 | 0.100 |
Why?
|
C-Reactive Protein | 2 | 2020 | 3821 | 0.090 |
Why?
|
Activated-Leukocyte Cell Adhesion Molecule | 1 | 2009 | 21 | 0.090 |
Why?
|
Superior Colliculi | 1 | 2009 | 98 | 0.080 |
Why?
|
Sarcoidosis | 1 | 2014 | 537 | 0.080 |
Why?
|
Odds Ratio | 1 | 2020 | 9648 | 0.070 |
Why?
|
Somatosensory Cortex | 1 | 2011 | 512 | 0.070 |
Why?
|
Logistic Models | 1 | 2020 | 13254 | 0.060 |
Why?
|
Humans | 10 | 2024 | 761098 | 0.060 |
Why?
|
Cell Adhesion Molecules | 1 | 2011 | 1603 | 0.060 |
Why?
|
Thalamus | 1 | 2011 | 1047 | 0.060 |
Why?
|
Motor Cortex | 1 | 2011 | 1007 | 0.050 |
Why?
|
Visual Cortex | 1 | 2011 | 1105 | 0.050 |
Why?
|
Agammaglobulinemia | 1 | 2024 | 171 | 0.050 |
Why?
|
Axons | 1 | 2011 | 1671 | 0.050 |
Why?
|
Follow-Up Studies | 1 | 2024 | 39121 | 0.050 |
Why?
|
Immunization, Passive | 1 | 2024 | 617 | 0.050 |
Why?
|
Visual Acuity | 1 | 2011 | 2677 | 0.050 |
Why?
|
Aged | 4 | 2024 | 169266 | 0.040 |
Why?
|
Aged, 80 and over | 2 | 2024 | 58946 | 0.040 |
Why?
|
Retina | 1 | 2009 | 2656 | 0.040 |
Why?
|
Longitudinal Studies | 3 | 2024 | 14607 | 0.040 |
Why?
|
Male | 6 | 2024 | 360675 | 0.030 |
Why?
|
Disease Progression | 1 | 2013 | 13506 | 0.030 |
Why?
|
Female | 6 | 2024 | 392458 | 0.030 |
Why?
|
Severity of Illness Index | 1 | 2013 | 15845 | 0.030 |
Why?
|
Retrospective Studies | 2 | 2024 | 80673 | 0.030 |
Why?
|
Brain Mapping | 1 | 2009 | 6635 | 0.030 |
Why?
|
Risk Factors | 1 | 2020 | 74219 | 0.030 |
Why?
|
Middle Aged | 4 | 2024 | 220835 | 0.030 |
Why?
|
Blood Sedimentation | 1 | 2013 | 235 | 0.030 |
Why?
|
Receptors, Interleukin-2 | 1 | 2013 | 564 | 0.020 |
Why?
|
United States | 1 | 2020 | 72337 | 0.020 |
Why?
|
Neuropilin-2 | 1 | 2011 | 55 | 0.020 |
Why?
|
Growth Cones | 1 | 2011 | 117 | 0.020 |
Why?
|
Neural Cell Adhesion Molecule L1 | 1 | 2009 | 44 | 0.020 |
Why?
|
Evoked Potentials, Visual | 1 | 2011 | 417 | 0.020 |
Why?
|
Mice, Mutant Strains | 1 | 2009 | 1750 | 0.020 |
Why?
|
Visual Pathways | 1 | 2009 | 551 | 0.020 |
Why?
|
Mice, Knockout | 2 | 2011 | 14393 | 0.020 |
Why?
|
Up-Regulation | 1 | 2013 | 4111 | 0.010 |
Why?
|
Animals, Newborn | 1 | 2009 | 2666 | 0.010 |
Why?
|
Retinal Ganglion Cells | 1 | 2009 | 810 | 0.010 |
Why?
|
Functional Laterality | 1 | 2009 | 2256 | 0.010 |
Why?
|
Cross-Sectional Studies | 2 | 2014 | 26068 | 0.010 |
Why?
|
Adult | 3 | 2024 | 221083 | 0.010 |
Why?
|
Nerve Tissue Proteins | 1 | 2011 | 4405 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2024 | 64670 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2013 | 15308 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2013 | 22157 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2011 | 7844 | 0.010 |
Why?
|
Mice | 2 | 2011 | 81324 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2009 | 16947 | 0.010 |
Why?
|
Cohort Studies | 1 | 2013 | 41486 | 0.010 |
Why?
|
Prospective Studies | 1 | 2013 | 54419 | 0.000 |
Why?
|
Animals | 2 | 2011 | 168083 | 0.000 |
Why?
|
Concepts
(81)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(14)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_